Management of systemic idiopathic juvenile arthritis in pediatrics with biological agents : a propos of a case
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2014 |
|---|---|
| Erschienen: |
2014 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:38 |
|---|---|
| Enthalten in: |
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria - 38(2014), 4 vom: 01. Juli, Seite 384-5 |
| Sprache: |
Spanisch |
|---|
| Weiterer Titel: |
Manejo de artritis idiopática juvenil sistémica en pediatría con agentes biológicos: a propósito de un caso |
|---|
| Beteiligte Personen: |
Brieva Herrero, M T [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
37CQ2C7X93 |
|---|
| Anmerkungen: |
Date Completed 23.06.2016 Date Revised 10.12.2019 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.7399/fh.2014.38.4.7368 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM241111021 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM241111021 | ||
| 003 | DE-627 | ||
| 005 | 20231224123538.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2014 xx |||||o 00| ||spa c | ||
| 024 | 7 | |a 10.7399/fh.2014.38.4.7368 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0803.xml |
| 035 | |a (DE-627)NLM241111021 | ||
| 035 | |a (NLM)25137173 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a spa | ||
| 100 | 1 | |a Brieva Herrero, M T |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Management of systemic idiopathic juvenile arthritis in pediatrics with biological agents |b a propos of a case |
| 246 | 3 | 3 | |a Manejo de artritis idiopática juvenil sistémica en pediatría con agentes biológicos: a propósito de un caso |
| 264 | 1 | |c 2014 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 23.06.2016 | ||
| 500 | |a Date Revised 10.12.2019 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a Letter | |
| 650 | 7 | |a Antibodies, Monoclonal |2 NLM | |
| 650 | 7 | |a Antibodies, Monoclonal, Humanized |2 NLM | |
| 650 | 7 | |a Biological Factors |2 NLM | |
| 650 | 7 | |a canakinumab |2 NLM | |
| 650 | 7 | |a 37CQ2C7X93 |2 NLM | |
| 700 | 1 | |a Pérez, I |e verfasserin |4 aut | |
| 700 | 1 | |a Cardenas, M |e verfasserin |4 aut | |
| 700 | 1 | |a Isla, B |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria |d 1998 |g 38(2014), 4 vom: 01. Juli, Seite 384-5 |w (DE-627)NLM093839022 |x 2171-8695 |7 nnns |
| 773 | 1 | 8 | |g volume:38 |g year:2014 |g number:4 |g day:01 |g month:07 |g pages:384-5 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.7399/fh.2014.38.4.7368 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 38 |j 2014 |e 4 |b 01 |c 07 |h 384-5 | ||